Scisparc Ltd (SPRC)

$0.64

-0.09

(-11.87%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $0.64
    $0.69
    $0.64
    downward going graph

    0.31%

    Downside

    Day's Volatility :6.86%

    Upside

    6.57%

    downward going graph
  • $0.64
    $15.86
    $0.64
    downward going graph

    0.31%

    Downside

    52 Weeks Volatility :95.98%

    Upside

    95.96%

    downward going graph

Returns

PeriodScisparc LtdIndex (Russel 2000)
3 Months
-47.3%
0.0%
6 Months
-80.92%
0.0%
1 Year
-95.35%
0.0%
3 Years
-99.64%
-19.4%

Highlights

Market Capitalization
2.4M
Book Value
$10.77
Earnings Per Share (EPS)
-14.43
Profit Margin
-177.91%
Operating Margin TTM
-309.37%
Return On Assets TTM
-33.12%
Return On Equity TTM
-73.37%
Revenue TTM
2.9M
Revenue Per Share TTM
7.06
Quarterly Revenue Growth YOY
-32.7%
Gross Profit TTM
1.0M
EBITDA
-5.3M
Diluted Eps TTM
-14.43
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Company Financials

FY18Y/Y Change
Revenue
838.0K
↑ 72.07%
Net Income
-8.5M
↑ 36.5%
Net Profit Margin
-1.0K%
↑ 265.08%
FY19Y/Y Change
Revenue
498.0K
↓ 40.57%
Net Income
-5.4M
↓ 37.09%
Net Profit Margin
-1.1K%
↓ 59.65%
FY20Y/Y Change
Revenue
550.0K
↑ 10.44%
Net Income
-3.5M
↓ 34.6%
Net Profit Margin
-637.64%
↑ 439.07%
FY21Y/Y Change
Revenue
1.1M
↑ 94.36%
Net Income
-5.8M
↑ 65.41%
Net Profit Margin
-542.66%
↑ 94.98%
FY22Y/Y Change
Revenue
1.3M
↑ 26.01%
Net Income
-2.6M
↓ 55.32%
Net Profit Margin
-192.43%
↑ 350.23%
FY23Y/Y Change
Revenue
2.9M
↑ 113.73%
Net Income
-5.1M
↑ 97.61%
Net Profit Margin
-177.91%
↑ 14.52%
Q1 FY23Q/Q Change
Revenue
1.3M
-
Net Income
3.2M
-
Net Profit Margin
235.12%
-
Q2 FY23Q/Q Change
Revenue
2.0M
↑ 46.4%
Net Income
-2.9M
↓ 190.94%
Net Profit Margin
-146.04%
↓ 381.16%
Q1 FY24Q/Q Change
Revenue
907.0K
↓ 54.01%
Net Income
-2.2M
↓ 22.15%
Net Profit Margin
-247.19%
↓ 101.15%
FY18Y/Y Change
Total Assets
4.6M
↓ 52.33%
Total Liabilities
4.5M
↑ 280.88%
FY19Y/Y Change
Total Assets
1.2M
↓ 74.69%
Total Liabilities
1.1M
↓ 74.57%
FY20Y/Y Change
Total Assets
2.6M
↑ 121.92%
Total Liabilities
1.1M
↓ 0.79%
FY21Y/Y Change
Total Assets
9.9M
↑ 287.19%
Total Liabilities
1.8M
↑ 56.94%
FY22Y/Y Change
Total Assets
10.6M
↑ 6.95%
Total Liabilities
4.2M
↑ 134.14%
FY23Y/Y Change
Total Assets
11.2M
↑ 5.44%
Total Liabilities
1.6M
↓ 61.62%
Q3 FY22Q/Q Change
Total Assets
22.5M
↑ 55.69%
Total Liabilities
14.1M
↑ 23.89%
Q4 FY22Q/Q Change
Total Assets
10.6M
↓ 52.77%
Total Liabilities
4.2M
↓ 70.54%
Q1 FY23Q/Q Change
Total Assets
10.6M
↑ 0.0%
Total Liabilities
4.2M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
9.9M
↓ 6.72%
Total Liabilities
3.1M
↓ 25.07%
Q4 FY23Q/Q Change
Total Assets
11.2M
↑ 13.04%
Total Liabilities
1.6M
↓ 48.78%
Q1 FY24Q/Q Change
Total Assets
11.2M
↑ 0.0%
Total Liabilities
1.6M
↑ 0.0%
FY18Y/Y Change
Operating Cash Flow
-7.1M
↑ 55.75%
Investing Cash Flow
-2.1M
↑ 3850.94%
Financing Cash Flow
1.5M
↓ 88.34%
FY19Y/Y Change
Operating Cash Flow
-4.7M
↓ 34.16%
Investing Cash Flow
1.3M
↓ 160.55%
Financing Cash Flow
2.8M
↑ 82.55%
FY20Y/Y Change
Operating Cash Flow
-4.3M
↓ 8.28%
Investing Cash Flow
24.0K
↓ 98.11%
Financing Cash Flow
5.4M
↑ 91.12%
FY21Y/Y Change
Operating Cash Flow
-5.1M
↑ 17.51%
Investing Cash Flow
-70.0K
↓ 391.67%
Financing Cash Flow
10.1M
↑ 87.72%
FY22Y/Y Change
Operating Cash Flow
-7.9M
↑ 56.43%
Investing Cash Flow
-7.1M
↑ 10020.0%
Financing Cash Flow
11.7M
↑ 16.3%
Q3 FY22Q/Q Change
Operating Cash Flow
-2.9M
↑ 30.92%
Investing Cash Flow
-3.2M
-
Financing Cash Flow
1.4M
↓ 84.75%
Q4 FY22Q/Q Change
Operating Cash Flow
-2.9M
↑ 0.0%
Investing Cash Flow
-3.2M
↑ 0.0%
Financing Cash Flow
1.4M
↑ 0.0%
Q1 FY23Q/Q Change
Operating Cash Flow
-5.7M
↑ 100.0%
Investing Cash Flow
-535.5K
↓ 83.2%
Financing Cash Flow
2.7M
↑ 100.0%
Q2 FY23Q/Q Change
Operating Cash Flow
-3.2M
↓ 43.57%
Investing Cash Flow
-535.5K
↑ 0.0%
Financing Cash Flow
2.8M
↑ 2.82%

Technicals Summary

Sell

Neutral

Buy

Scisparc Ltd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Scisparc Ltd
Scisparc Ltd
-28.02%
-80.92%
-95.35%
-99.64%
-99.64%
Moderna, Inc.
Moderna, Inc.
-9.87%
21.5%
-2.91%
-60.58%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
1.84%
12.81%
47.11%
81.12%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-6.7%
24.69%
59.95%
200.63%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.28%
11.69%
35.86%
150.1%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Scisparc Ltd
Scisparc Ltd
0.0
NA
NA
0.0
-0.73
-0.33
NA
10.77
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Scisparc Ltd
Scisparc Ltd
NA
$2.4M
-99.64%
0.0
-177.91%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Scisparc Ltd

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 59.9% return, outperforming this stock by 155.3%

Institutional Holdings

  • UBS Group AG

    0.29%
  • Rhumbline Advisers

    0.11%

Company Information

Organization
Scisparc Ltd
Employees
3
CEO
Mr. Oz Adler CPA
Industry
Miscellaneous

FAQs